Baim Institute for Clinical Research

• This Will be a Randomized Comparison of the Proteomic Effects of Vicadrostat/Empagliflozin Versus Empagliflozin and Versus Empagliflozin/Spironolactone in Heart Failure Patients With Preserved Ejection Fraction

  Phase 2, Not yet recruiting, 200 people, 5 Oct 2026

• NORM-HF Pivotal Study

  Collaborator, Recruiting, 800 people, 8 May 2026

• NCT03750760

  Collaborator, Phase 4, Withdrawn, 0 people, 23 Nov 2018

• NCT01106534

  Collaborator, Phase 4, Completed, 870 people, 20 Apr 2010

• NCT00977938

  Phase 4, Completed, 25,682 people, 16 Sept 2009

Sources: clinicaltrials.gov

• Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial

  Fees or honoraria, 16 Sept 2026

• Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study

  Board or leadership role, 28 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov